CRA was hired by a biotech company with a new product in development for oncology. The main objective was to quantitatively understand current treatment dynamics and future market opportunity. We evaluated multiple data sources and developed patient flow and market map for two tumor types, using a patient-level claim data. We further created competitive landscape assessment and identified target intervention points for each scenario, in collaboration with the client. Research was conducted for both US and EU5 to size the global commercial opportunity.
Best practices for grounding brand decision-making in insights
In today’s evolving pharmaceutical landscape, harnessing the power of insights is more critical than ever. Integrating primary, secondary, and analytical...